On November 11, 2021, Compugen Ltd. closed the transaction. The company announced a private placement of 2,332,815 shares at a price of $8.57333 per share for gross proceeds of $19,999,992.82395. The transaction included participation from returning investor, Bristol-Myers Squibb Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.01 USD | -0.23% | -2.07% | -14.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.23% | 8.93TCr | |
+32.09% | 69TCr | |
+29.39% | 58TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Compugen Ltd. announced that it has received $19.999993 million in funding from Bristol-Myers Squibb Company